Publications
The work of our scientists, research associates, and staff are often found in the pages of top journals. Each year, our researchers publish over 400 peer-reviewed papers.
Outpatient versus inpatient intravenous antimicrobial therapy: a population-based observational cohort study of adverse events and costs
Clin Infect Dis
April 19, 2022
Read MoreStaples JA, Ho M, Ferris D, Hayek J, Liu G, Tran KC, Sutherland JM
Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study
Read MoreLee T, Cheng MP, Vinh DC, Lee TC, Tran KC, Winston BW, Sweet D, Boyd JH, Walley KR, Haljan G, McGeer A, Lamontagne F, Fowler R, Maslove D, Singer J, Patrick DM, Marshall JC, Burns KD, Murthy S, Mann PK, Hernandez G, Donohoe K, Rocheleau G, Russell JA; for the ARBs CORONA I study investigators
The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis
Read MoreMcGuire AL, McConechy MK, Melosky BL, English JC, Choi JJ, Peng D, Yee J, Furman BLS, Hernandez RA, Feijao P, Mulder D, Hughesman C, Yip S
Rituximab for Adults With Multi-Drug Resistant Focal Segmental Glomerulosclerosis: A Case Series and Review of the Literature
Read MoreZhong E, Ghadiri S, Pai A, Marin JG, Barbour SJ
Sex Differences in the Management of Oral Anticoagulation and Outcomes for Emergency Department Presentation of Incident Atrial Fibrillation
Ann Emerg Med
April 22, 2022
Read MoreIslam S, Dover DC, Daniele P, Hawkins NM, Humphries KH, Kaul P, Sandhu RK
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials
Read MoreTuttle KR, Levin A, Nangaku M, Kadowaki T, Agarwal R, Hauske SJ, Elsäßer A, Ritter I, Steubl D, Wanner C, Wheeler DC
COVID-19 Vaccine Intentions and Perceptions Among Public School Staff of the Greater Vancouver Metropolitan Area, British Columbia, Canada
Read MoreWatts AW, Hutchison SM, Bettinger JA, Gadermann A, Oberle E, Oberlander TF, Goldfarb DM, Lavoie PM, Mâsse LC
The rationale for the need to study sodium-glucose co-transport 2 inhibitor usage in peritoneal dialysis patients
Read MoreBorkum M, Jamal A, Singh RS, Levin A
OASIS guideline adherence among Canadian maternity care providers: A research letter
Read MoreTilak M, Koenig N, Albert A, Mayer U, Gipson T, Sim A, Geoffrion R
Effects of dapagliflozin on volume status and systemic hemodynamics in patients with CKD without diabetes: Results from DAPASALT and DIAMOND
Read MoreSen T, Scholtes R, Greasley PJ, Cherney D, Dekkers CCJ, Vervloet M, Danser AHJ, Barbour S, Karlsson C, Hammarstedt A, Li Q, Laverman GD, Bjornstad P, van Raalte DH, Heerspink HJL
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
Read MoreBarbour SJ, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Er L, Reich HN, Barratt J, Cattran DC
Relating person-centredness to quality-of-life assessments and patient-reported outcomes in healthcare: A critical theoretical discussion
Read MoreAndersson V, Sawatzky R, Öhlén J